154 related articles for article (PubMed ID: 37637544)
1. Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report.
Pramanik D; Bhardwaj D; Karmani VK; Raval GG; Kutlar A
Cureus; 2023 Jul; 15(7):e42423. PubMed ID: 37637544
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report.
Chaurasiya PS; Khatri A; Gurung S; Karki S; Shahi S; Aryal L
Ann Med Surg (Lond); 2022 Oct; 82():104789. PubMed ID: 36268380
[TBL] [Abstract][Full Text] [Related]
3. Successful use of a second course of caplacizumab in relapsed thrombotic thrombocytopenic purpura.
Shaffer J; Grove A
Platelets; 2022 Jul; 33(5):790-791. PubMed ID: 34565299
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X
Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618
[TBL] [Abstract][Full Text] [Related]
5. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
[TBL] [Abstract][Full Text] [Related]
6. Refractory Auto-Immune Thrombotic Thrombocytopenic Pupura Successfully Treated With Caplacizumab.
Mellaza C; Henry N; Fayolle PM; Mortaza S; Subra JF; Veyradier A; Coppo P; Augusto JF
Front Med (Lausanne); 2020; 7():549931. PubMed ID: 33195299
[TBL] [Abstract][Full Text] [Related]
7. A Rare Case of Severe Manifestation of COVID-19 Infection Presenting as Immune-Related Thrombotic Thrombocytopenic Purpura With Multiorgan Involvement Treated With Plasmapheresis, Steroids, Rituximab, and Caplacizumab.
Mandyam S; Fatmi SS; Banzon G; Kaur P; Katamreddy Y; Parghi D; Farooq A; Liaqat H; Basarakodu K
Cureus; 2022 Jul; 14(7):e26961. PubMed ID: 35989829
[TBL] [Abstract][Full Text] [Related]
8. Caplacizumab as rescue therapy in refractory TTP involving neurologic features.
Tran MH; Lee LX; Cao Y; Vu L; Pakbaz Z
Transfus Apher Sci; 2023 Jun; 62(3):103656. PubMed ID: 36863912
[TBL] [Abstract][Full Text] [Related]
9. An Interesting Case of Refractory Thrombotic Thrombocytopenic Purpura in the First Trimester of a Twin Pregnancy.
Jacob G; Dhaliwal A; Chaudhary V
Cureus; 2023 Oct; 15(10):e47153. PubMed ID: 38021667
[TBL] [Abstract][Full Text] [Related]
10. Systemic Lupus Erythematosus (SLE) and Thrombotic Thrombocytopenic Purpura (TTP) Presenting as Recurrent Strokes: A Case Report.
Kadam A; Toshniwal S; Acharya S; Shukla S
Cureus; 2024 May; 16(5):e60238. PubMed ID: 38872677
[TBL] [Abstract][Full Text] [Related]
11. Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience.
Tse B; Buchholz M; Pavenski K
Platelets; 2023 Dec; 34(1):2157807. PubMed ID: 36636834
[TBL] [Abstract][Full Text] [Related]
12. Caplacizumab in the successful management of cardiac involvement in thrombotic thrombocytopenic purpura.
Mahmoud AA; Eltaher B; Hashem A
Proc (Bayl Univ Med Cent); 2022; 35(6):832-833. PubMed ID: 36304630
[TBL] [Abstract][Full Text] [Related]
13. Caplacizumab for relapsing thrombotic thrombocytopenic purpura.
Kaczmarek V; Holle J; Astudillo R; Kempf C; Bufler P; Müller D
Pediatr Nephrol; 2019 Sep; 34(9):1625-1628. PubMed ID: 31177334
[TBL] [Abstract][Full Text] [Related]
14. Caplacizumab Use in a TTP Case Unresponsive to Conventional Therapy.
William J; McCellistrim C; Nuñez Y
Ir Med J; 2022 Sep; 115(8):656. PubMed ID: 36327969
[TBL] [Abstract][Full Text] [Related]
15. Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI).
Cid J; Pérez-Valencia AI; Torrente MÁ; Ávarez-Larrán A; Díaz-Ricart M; Esteve J; Lozano M
Transfus Apher Sci; 2021 Feb; 60(1):103011. PubMed ID: 33221124
[TBL] [Abstract][Full Text] [Related]
16. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
17. Role of the PLASMIC Score in the Management of Thrombotic Thrombocytopenic Purpura.
Vyas A; Isaac S; Kaur D; Yadav U
Cureus; 2023 Mar; 15(3):e36188. PubMed ID: 37065284
[TBL] [Abstract][Full Text] [Related]
18. Near-complete vision recovery from bilateral serous retinal detachment associated with thrombotic thrombocytopenic purpura.
Nguyen T; Radhakrishnan SM; Radhakrishnan SJ; Johnson DH
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35131768
[TBL] [Abstract][Full Text] [Related]
19. Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab.
Cilla N; Dallemagne J; Vanhove M; Stordeur P; Motte S; De Wilde V
J Hematol; 2020 Sep; 9(3):84-88. PubMed ID: 32855757
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab.
Völker LA; Brinkkoetter PT; Knöbl PN; Krstic M; Kaufeld J; Menne J; Buxhofer-Ausch V; Miesbach W
J Thromb Haemost; 2020 Nov; 18(11):3061-3066. PubMed ID: 32757435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
